Drug Enforcement D-0527-2023

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Status

Ongoing

Classification

Class II

Report Date

April 12, 2023

Termination Date

Product Information

Product description
Glimepiride Tablets USP, 4 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8066-9
Product quantity
15 Bottles
Reason for recall
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
USA Nationwide

Location & Firm

Recalling firm
Preferred Pharmaceuticals, Inc.
Address
1250 N Lakeview Ave Ste O

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-0527-2023
Event ID
91952
Recall initiation date
March 23, 2023
Center classification date
April 6, 2023
Code info
Lot: H1221Z, I0121J, J0622X, Exp 10/31/2023.
More code info